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Alcohol is a knownmodulator of the innate immune system. Owing to the absence of human studies, alcohol’s effect on circulating
cytokine profile remains unclear. We investigated the effect of acute high dose alcohol consumption on systemic cytokine release.
After an overnight fasting, alcohol-experienced healthy male volunteers (𝑁 = 20) aged 25–45 years were given oral ethanol in the
form of vodka (4.28mL/kg) which they drank over a period of 30 minutes reaching peak blood alcohol concentration of 0.12% (SD
0.028). Blood samples were obtained prior to alcohol intake as well as 2, 7, and 12 hours thereafter. Serum levels of the inflammatory
cytokines IL-1𝛽, IL-1Ra, IL-6, IL-10, IL-17, IFN-𝛾, MCP-1, and TNF-𝛼 were determined by the multibead-based assay. Baseline
cytokine levels were not related to BMI, hepatic parameters, electrolytes, glucose, or morning cortisol levels. Within 2 hours of
alcohol intake, levels of IL-1Ra were elevated and remained so throughout the assessment period (𝑝 for trend = 0.015). In contrast,
the levels of the chemokineMCP-1 dropped acutely followed by steadily increasing levels during the observation period (𝑝 < 0.001).
The impact of sustained elevated levels of MCP-1 even after the clearance of blood alcohol content deserves attention.
1. Introduction
Alcohol is a known modulator of the immune system affect-
ing innate as well as adaptive arms of the host immune
response. Excessive and chronic heavy drinking, as typi-
fied in alcohol use disorder (AUD), induces systemic and
CNS inflammation [1] which contribute to the development
of a number of alcohol-attributable chronic diseases and
conditions [2]. One widely proposed mechanism for innate
immune response in chronic heavy alcohol consumption
involves alcohol-induced changes in the composition of gut
microbiome [3] and compromised gut wall integrity [4]
allowing bacterial products such as lipopolysaccharide (LPS)
to “leak” into systemic circulation which promotes secre-
tion of proinflammatory cytokines including tumor necrosis
factor-alpha (TNF-𝛼) and interleukin- (IL-) 1𝛽 through Toll-
like receptor mediated activation of transcription factors,
such as nuclear factor-𝜅B [5, 6]. High dose alcohol exposure
can induce neuroimmune signaling even after a single alcohol
binge [7, 8] and immune stimuli such as LPS may not be
necessary for inducing these changes [9, 10].
A recent study [11] demonstrated increased hippocampal
IL-10 content in adult rats one hour after a single intoxicating
intragastric dose of ethanol (5 g/kg). In mice pretreated
with ethanol, Qin and colleagues found that LPS-induced
production of TNF-𝛼, IL-1𝛽, and monocyte chemoattractant
protein 1 (MCP-1, also known as CCL
2
) were elevated in
the liver, serum, and brain [12]. Increases in serum cytokine
levels subsided by 9 hours with clearance of blood alcohol
content. Importantly, the same group discovered that a single
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immune stimulus was sufficient to activate brain microglia to
produce chronically elevated inflammatory factors in rodent
models [13]. These lines of evidence suggest that occasional
ethanol intoxication can have far-reaching consequences
through neuroimmune modulation. However, the nature of
those consequences is unclear because of the paucity of
experimental alcohol studies in humans.
Generally, acute alcohol exposure (usually defined as less
than 24 hrs) favors anti-inflammatory response and chronic
alcohol consumption favors proinflammatory cytokine
release [14, 15]. For instance, healthy men and women 20
minutes after binge alcohol consumption (0.9 g/kg in men
and 0.8 g/kg in women) were found to have elevated blood
leukocytes, monocytes, natural killer cells, and LPS-induced
TNF-𝛼 production which switched towards anti-inflamma-
tory direction after 2 hours [7]. The dynamic of the immune
response, thus, seems to be more complex and depends on
the dose as well as time duration since alcohol intake. This
study aimed to further elucidate the effects of binge alcohol
intoxication in physiologically relevant conditions in humans
by assessing changes in serum cytokine levels up to 12 hours
after drinking.
2. Materials and Methods
2.1. Study Participants. Healthy volunteers were recruited
through an open advertisement in the Correctional Service
of Norway Staff Academy in Oslo. Inclusion criteria were
male gender, age 20–45 years, and Caucasian origin who
admitted having experiences of high dose alcohol drinking
sometime in the past. Exclusion criteria were significant
medical illness, alcohol or other substance use disorders, and
metabolic disorders.
Volunteers interested in participating in the study were
invited to be screened for AUD as well as physical and psy-
chological health. Demographic information was recorded
and biochemical parameters were determined by venous
blood drawn after an overnight fasting. Participants had no
active inflammation at the time of experiment indicated by
prealcoholCRP levels< 20.AUDscreeningwas done by using
the Alcohol Use Disorder Identification Test (AUDIT) [16].
All individuals scored below 15 in theAUDIT scale, consistent
with being nondependent on alcohol. This was confirmed by
measuring serum carbohydrate deficient transferrin (CDT)
value at baseline which was <1.7% in all participants.
2.2. Experimental Setup. The experiment was a part of a
drug trial on ethanol metabolism based on a double-blind
crossover design investigating the impact of phosphate sup-
plement on ethanol metabolism. Participants showed up at
the experiment location at 07:00 in the morning following
an overnight fasting. Baseline blood samples were taken
15 minutes after arrival and then a light breakfast was
served. After thirty minutes participants were served oral
ethanol in the form of vodka (38% by volume) in a dose of
4.28mL/kg which they drank over a period of 30 minutes
reaching peak blood alcohol concentration of 0.12% (SD
0.028). Participants were allowed standard meals and indoor
activities throughout experiment.
In addition to prealcohol samples (T
1
) obtained in the
fasting state, venous blood samples were obtained from the
cubital region (cephalic or median cubital vein) a total of
10 times during 12 hours of observation. Sampling at 2 (T
2
),
7 (T
3
), and 12 hours (T
4
) after alcohol intake was used for
cytokine assays. Intervention and control solutions used in
the experiment contained elemental phosphate and dextrose
based drinks which are not known to impact cellular immune
response. The experiment was repeated after one week swap-
ping the intervention and control group participants making
individuals their own controls.
2.3. Background Variables. Background variables were reg-
istered under the categories somatic, psychological, and
anthropometric variables. History of specific organ damage,
chronic inflammatory conditions, and atopy was inquired.
Recent use of drugs of abuse and alcohol use-related adverse
consequences, such as subjective dose required for intoxica-
tion, and vomiting were also recorded. Body mass index was
calculated as weight (Kg)/height (m)2. Routine biochemistry
was done on all participants 10 days prior to the first
experiment day to determine eligibility and to assess baseline
values.
2.4. Laboratory Analyses. Routine biochemical tests for
screening purpose included blood hemoglobin, C-reactive
protein, mean corpuscular volume and hemoglobin, serum
glucose, CDT, gammaglutamyl transferase (GGT), creatinine,
phosphorus, and alanine aminotransferase enzyme assays.
Blood alcohol concentrations were measured at ten times
during the observation and supplemented by six breathalyzer
readings.
Cytokine measurements were performed using a
Luminex IS 100 instrument (Bio-Rad, Hercules, California,
USA), equipped with the Bio-Plex Manager software
(version 6.0.1). A custom-made kit was purchased to screen
all samples consisting of the cytokines IL-1𝛽, IL-1Ra, IL-6,
IL-10, IL-17, IFN-𝛾, MCP-1, and TNF-𝛼. Individual sets of
samples from one participant were run in the same assay
but kept blinded. All samples were thawed on ice, vortexed,
and then spun down at 10.000×g for 10min at 4∘C, before
dilution (1 + 4) and further processing. The assay was
performed according to the manufacturer’s instructions,
except for the additional standard point to enable low level
detection. All cytokine assays were performed in duplicate.
Longitudinal control was used to determine inter-% CV to
evaluate assay performance of the assay (IL-1𝛽 (5.6), IL-Ra
(4.1), IL-6 (5.5), IL-10 (5.3), IL-17 (6.2), IFN-𝛾 (7.1), MCP-1
(5.4), and TNF-𝛼 (5.3)). The results for the serum samples
that were found to have levels lower than the detectable limit
(set at 0) were IL-1𝛽 (22%), IL-1Ra (0%), IL-6 (60%), IL-10
(69%), IL-17 (84%), IFN-𝛾 (92%), MCP-1 (8%), and TNF-𝛼
(76%). This number of missing data was not different across
the 4 time points of observation. Therefore, we are reporting
only IL-1𝛽, IL-1Ra, and MCP-1 in the results.
2.5. Statistical Analyses. The statistical analysis was per-
formed using IBM SPSS Statistics for Windows version
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22 (IBM Corp., Armonk, NY). Cytokine data had skewed
distribution and therefore we chose nonparametric tests
(Mann–Whitney 𝑈 test, Kruskal–Wallis test, and Spearman’s
rho) for comparisons. Results were considered significant
when 𝑝 < 0.05. Pairwise comparisons were made for
cytokine changes over time using general linear models
with Bonferroni corrections when needed. Relative changes
between the levels of each cytokines were compared using
correlation matrix on respective first principal components
of the principal component analysis [17].
2.6. Ethics. The study protocol was approved by the Norwe-
gian Regional Ethics Committee (REK case ref. 2013/1563).
Prior to inclusion, written informed consent was obtained
from all participants. Participants were fully entitled to with-
draw their consent at any time during the study.They received
bank transfer amounting Norwegian Kroner 2000/day in
compensation to the time incurred for the experiment and
taxi fare was paid to return home after the experiment.
All participants were ensured as part of the project leader’s
membership with the Norwegian Drug Liability Association
(ref. 5041916/1) which covers eventualities in connection with
a clinical drug trial.
3. Results
The participant characteristics including demographics,
AUDIT scores, biochemical parameters, and allergic history
are given in Table 1. The prealcohol (T
1
) and subsequent (T
2
,
T
3
, and T
4
) levels of IL-1𝛽, IL-1Ra, and MCP-1 did not vary
between the two experimental days. T
1
levels of IL-1Ra and
MCP-1 on experimental days 1 and 2 were highly correlated
(𝜌 = 0.91; 𝑝 < 0.001 and 𝜌 = 0.82; 𝑝 < 0.001, resp.). The
variations in the cytokine levels across the observation period
were represented by the respective principal components
found in the principal component analysis.The first principal
component (FPC1) of IL-1Ra andMCP-1 explainedmore than
90% of all variations in these cytokine values over time. The
FCP1s for IL-1Ra andMCP-1were highly correlated (𝜌 = 0.64,
𝑝 < 0.001). Phosphate intervention given as part of the
drug trial had no effect on the cytokine levels on either day
(𝑝 > 0.05 for all test results). Among the analytes included,
T
1
levels of IL1Ra correlated with baseline MCV values (𝜌 =
0.66, 𝑝 = 0.002) and T
1
levels of MCP-1 correlated with
serum GGT levels (𝜌 = 0.522, 𝑝 = 0.02). The cytokines were
unrelated to age, BMI, or AUDIT scores (𝑝 > 0.05 for all
correlation analyses).
Blood alcohol contentmeasured directly aswell as breath-
alyzer estimates showed normal peak and elimination curve
(Figure 1). IL-1𝛽 levels did not change over the observation
period (𝑝 = 0.077) (Figure 2(a)). However, IL-1Ra andMCP-
1 levels changed significantly (𝑝 = 0.015 and 𝑝 < 0.001,
resp.). Within 2 hours of alcohol intake, levels of IL-1Ra were
elevated and remained so throughout the assessment period.
The levels of MCP-1 however dropped acutely followed
by steadily increasing levels during the observation period
which remained higher than baseline (𝑝 = 0.025) at the 12th
hour (Figure 2(b)).
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Figure 1: Elimination curve of ethanol following binge drinking
of vodka amounting 4.28mL/kg body weight as assessed by blood
ethanol content and breathalyzer estimate.
4. Discussion
We investigated in a cohort of healthy men the changes in
serum levels of inflammatory cytokines following alcohol
intake in a euphoric dose. Results demonstrate an early
cytokine response followed by changes that may last beyond
complete elimination of ethanol from circulation. This find-
ing extends earlier suggestions stemming from in vitro and
preclinical works that high dose ethanol can trigger long-
lasting innate immune responses [12, 18]. Here we show in
vivo changes in cytokine levels following alcohol intoxication
which seems to be independent of an ongoing traumatic
injury or infection. These findings are important because
alcohol-induced changes in cytokine pathways with and
without an immune challenge can manifest in a range of
mood and behavioral disorders, particularly in the context of
chronic heavy drinking [19].
Findings from this study are in line with a handful
of human studies that have been previously conducted
examining direct effects of alcohol intoxication on cytokine
response. Not only binge does drinking in healthy individ-
uals rapidly increase serum LPS through compromised gut
wall integrity but also the same dose of LPS ex vivo can
induce production of proinflammatory cytokines, TNF-𝛼, IL-
6, and MCP-1 [8]. We demonstrate postalcohol induction of
inflammatory cytokineMCP-1 in vivo within hours following
an apparently acute fall in value that corresponds with
opposing changes in IL-1Ra which has an anti-inflammatory
effect. Indeed, acute increases in the levels of another anti-
inflammatory cytokine IL-10 have been demonstrated also
in the brain of rats fed with high dose ethanol [11]. The
changes in the levels of IL-1Ra may not be coincidental as it
is essential for alcohol drinking preference typical of AUD
[20]. Also, our data shows an association between GGT, a
measure of alcohol-induced liver injury, and MCP-1 levels.
Although higher values of cytokines are not expected in
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Figure 2: (a) Serum levels (mean and standard error of mean) of IL-1𝛽 at baseline and 2, 7, and 12 hours after binge drinking of alcohol.
No statistically significant trend or differences between observations were found. (b) Serum levels (mean and standard error of mean) of
IL-1Ra andMCP-1 at baseline and 2, 7, and 12 hours after binge drinking of alcohol. Statistically significant changes from prebinge values were
observed at T
2
for IL-1Ra and at T
2
and T
4
for MCP-1 and are indicated by an ∗. Trend statistics were significant for both cytokines.
normal physiology, the detectable ranges of IL-1𝛽, IL-1Ra, and
MCP-1 are among the most commonly reported cytokines
that could be important candidate immune mediators in
alcohol-induced tissue injury and long-term psychiatric and
behavioral outcomes. Clearly, MCP-1 expression levels have
been found to be uniquely related to blood alcohol content
[21]. MCP-1 is responsible for recruitment and activation of
monocytes in the process of alcohol liver disease [22]. In
specific brain areas of rodents that regulate drinking behavior,
MCP-1 has been found colocalized and overexpressed with
Toll-like receptor 4, a potent sensor of LPS [23, 24]. This
supports the role of MCP-1 in alcohol use disorder.
In the context of heavy drinking, LPS-induced pro-
duction of the cytokines TNF-𝛼, MCP-1, and IL-1𝛽 are
potentiated [12]. A high degree of correlation between the
MCP-1, a proinflammatory chemokine, and IL-1Ra, an anti-
inflammatory cytokine, on both experimental days indicates
that, under physiological conditions, a balanced pro- and
anti-inflammatory state is maintained. During the first hours
of alcohol intake, rise in the level of IL-1Ra was accompanied
by a fall in MCP-1 levels. The balance persisted over the
course of the observation period in which changes in the
cytokine levels were found. Since prealcohol cytokine levels
were similar on the two experimental days our findings
do not support a spillover effect of alcohol sensitization
of immunologically active cells to produce higher levels of
cytokines in the context of occasional heavy drinking.
A limitation to this study is that cytokine changes were
not compared against a normal diurnal variation. Although
cytokine profile has been found to vary according to the
sampling hour of the day, the difference is less marked in
serum samples compared to the plasma [25]. Some inflam-
matory cytokines, but not anti-inflammatory cytokines, seem
to increase slightly with diurnal reduction in cortisol levels
[25, 26]. Also, several animal studies have indicated that
ethanol administration in itself can induce production of
inflammatory cytokines and chemokines in the brain as
well as in the periphery [27, 28]. With the present data,
we are unable to comment on whether the subtle changes
observed in serum translate into CNS changes. The study
samples, like most other experimental human studies, are too
small to compare between different variables and subgroups
of individuals, such as the interaction of atopy in alcohol-
related immune changes. Larger samples are required to
increase power and to limit type II error. Alcohol-immune
interaction in the face of concurrent immune-inflammatory
conditions should be investigated in future studies. Including
only healthy male subjects in the middle age avoided gender-
and ageing-related differences in cytokines. Although the
findings provide important insight into occasional heavy
drinking, the response of immune cells potentially sensitized
after prolonged alcohol exposure needs to be examined in a
clinical sample.
In summary, this study demonstrates that binge drink-
ing provokes an early cytokine response favoring anti-
inflammatory state, as indicated by elevated IL-1Ra levels, fol-
lowed by a gradual change towards the baseline levels, which
are not attained even when ethanol is fully eliminated from
the blood. On the contrary, the levels of the proinflammatory
chemokine MCP-1 increased after initial drop and remained
higher than baseline levels at 12-hour follow-up. Allostatic
changes in neuroimmune parameters upon repeated alcohol
challenge may underlie a range of alcohol-related diseases
and injuries.
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